|
Amgen's Anemia Drug Aranesp Is Safe Before Kidney Dialysis, FDA Panel Says - Bloomberg |
|
|
|
BloombergEliminating pre- dialysis use may shave $200 million to $400 million from Amgen's annual sales, or 5 to 10 cents from per-share earnings, said Michael Yee, ...
|